126 related articles for article (PubMed ID: 3487832)
1. The oncogenic activation of human p21ras by a novel mechanism.
Walter M; Clark SG; Levinson AD
Science; 1986 Aug; 233(4764):649-52. PubMed ID: 3487832
[TBL] [Abstract][Full Text] [Related]
2. Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding.
Clark R; Wong G; Arnheim N; Nitecki D; McCormick F
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5280-4. PubMed ID: 3927300
[TBL] [Abstract][Full Text] [Related]
3. Comparative biochemical properties of normal and activated human ras p21 protein.
McGrath JP; Capon DJ; Goeddel DV; Levinson AD
Nature; 1984 Aug 23-29; 310(5979):644-9. PubMed ID: 6147754
[TBL] [Abstract][Full Text] [Related]
4. Activation of the cellular proto-oncogene product p21Ras by addition of a myristylation signal.
Buss JE; Solski PA; Schaeffer JP; MacDonald MJ; Der CJ
Science; 1989 Mar; 243(4898):1600-3. PubMed ID: 2648572
[TBL] [Abstract][Full Text] [Related]
5. Biological and biochemical properties of human rasH genes mutated at codon 61.
Der CJ; Finkel T; Cooper GM
Cell; 1986 Jan; 44(1):167-76. PubMed ID: 3510078
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the conformation and GTP hydrolysing ability of N-terminal ras p21 protein segments.
Niu CH; Han KH; Roller PP
Biochem Biophys Res Commun; 1989 Apr; 160(1):282-8. PubMed ID: 2785386
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of polypeptides encoded by mutated human Ha-ras1 genes.
Colby WW; Hayflick JS; Clark SG; Levinson AD
Mol Cell Biol; 1986 Feb; 6(2):730-4. PubMed ID: 3537694
[TBL] [Abstract][Full Text] [Related]
8. Regional homology in GTP-binding proto-oncogene products and elongation factors.
Halliday KR
J Cyclic Nucleotide Protein Phosphor Res; 1983-1984; 9(6):435-48. PubMed ID: 6396323
[TBL] [Abstract][Full Text] [Related]
9. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
Velasco JA; Avila MA; Notario V
Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
[TBL] [Abstract][Full Text] [Related]
10. Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p21.
Finkel T; Der CJ; Cooper GM
Cell; 1984 May; 37(1):151-8. PubMed ID: 6609772
[TBL] [Abstract][Full Text] [Related]
11. The ras gene family.
Lowy DR; Willumsen BM
Cancer Surv; 1986; 5(2):275-89. PubMed ID: 3096566
[TBL] [Abstract][Full Text] [Related]
12. Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide.
Peace DJ; Smith JW; Chen W; You SG; Cosand WL; Blake J; Cheever MA
J Exp Med; 1994 Feb; 179(2):473-9. PubMed ID: 8294861
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor stimulates guanine nucleotide binding activity and phosphorylation of ras oncogene proteins.
Kamata T; Feramisco JR
Nature; 1984 Jul 12-18; 310(5973):147-50. PubMed ID: 6610834
[TBL] [Abstract][Full Text] [Related]
14. Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein.
Feramisco JR; Clark R; Wong G; Arnheim N; Milley R; McCormick F
Nature; 1985 Apr 18-24; 314(6012):639-42. PubMed ID: 2581140
[TBL] [Abstract][Full Text] [Related]
15. Activation of Ha-ras p21 by substitution, deletion, and insertion mutations.
Chipperfield RG; Jones SS; Lo KM; Weinberg RA
Mol Cell Biol; 1985 Aug; 5(8):1809-13. PubMed ID: 3018526
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form.
Chen JM; Lee G; Murphy RB; Carty RP; Brandt-Rauf PW; Friedman E; Pincus MR
J Biomol Struct Dyn; 1989 Apr; 6(5):859-75. PubMed ID: 2686707
[TBL] [Abstract][Full Text] [Related]
17. Mutant ras-encoded proteins with altered nucleotide binding exert dominant biological effects.
Sigal IS; Gibbs JB; D'Alonzo JS; Temeles GL; Wolanski BS; Socher SH; Scolnick EM
Proc Natl Acad Sci U S A; 1986 Feb; 83(4):952-6. PubMed ID: 3513168
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
19. Oncogenes and metastatic progression.
Greenberg AH; Egan SE; Wright JA
Invasion Metastasis; 1989; 9(6):360-78. PubMed ID: 2689384
[TBL] [Abstract][Full Text] [Related]
20. Detection of activated Mr 21,000 protein, the product of ras oncogenes, using antibodies with specificity for amino acid 12.
Wong G; Arnheim N; Clark R; McCabe P; Innis M; Aldwin L; Nitecki D; McCormick F
Cancer Res; 1986 Dec; 46(12 Pt 1):6029-33. PubMed ID: 3490906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
